New Jersey Kidney Care

Jersey City, New Jersey 07305

1 studies enrolling now · 4 studies all time

What they study most

End Stage Kidney Disease, Glomerular Disease, IgA Nephropathy, Primary IgA Nephropathy, Proteinuria

Studies at this site

• Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD) — Recruiting now
• A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy — Running, not enrolling
• Study of Efficacy and Safety of LNP023 in Primary IgA Nephropathy Patients — Completed
• Study of Safety and Efficacy of ANG-3070 in Chronic Kidney Disease — Status unconfirmed